H.R. 2365 118th Congress
Dr. Emmanuel Bilirakis and Honorable Jennifer Wexton National Plan to End Parkinson’s Act
- Became Public Law 118-66
- Health
- Sponsor: Gus M. Bilirakis
- Congress.gov ↗
Latest action, Jul 2, 2024: Became Public Law No: 118-66.
How the House voted: On Motion to Suspend the Rules and Pass, as Amended
Dec 14, 2023 · Passed · 407–9 (it needed 2/3)
- Yea (407)
- Nay (9)
- Didn't vote (18)
- Letters: party (D, R, I)
By party
- Democrat
- Republican
- Independent
172 cosponsors
Sponsored by Gus M. Bilirakis (Republican). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
115 D · 57 R
- Democrat
- Republican
- Independent
Referred to: Senate: Health, Education, Labor, and Pensions Committee; House: Energy and Commerce Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
6 reports
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH
LEWIS-BURKE ASSOCIATES, LLC
2 reports
All 3 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | House |
|---|---|---|---|---|---|---|
| THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH | 8 | $560K | Q1 2023 | Q3 2024 | yes | |
| ACADIA PHARMACEUTICALS | 6 | $1.9M | Q4 2023 | Q3 2024 | yes | |
| THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH | LEWIS-BURKE ASSOCIATES, LLC | 2 | $0 | Q4 2023 | Q1 2024 | yes |